This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Shota Ikeda: Innovator in Heart Failure Research
Introduction
Shota Ikeda is a prominent inventor based in Ikeda, Japan. He has made significant contributions to the field of medical research, particularly in the area of heart failure. His innovative work has led to the development of a unique animal model that aids in the screening of substances for preventing and treating heart failure.
Latest Patents
Shota Ikeda holds a patent for a "Method of constructing heart failure model animal." This invention involves a non-human mammal that is effectively applicable for screening substances aimed at preventing and treating heart failure. The model is created by inducing both coronary stenosis and stenosis of arteries other than the coronary artery and the abdominal artery within the same timeframe.
Career Highlights
Ikeda is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has been instrumental in advancing research and development in cardiovascular health. He has a total of 1 patent to his name, showcasing his innovative contributions to the field.
Collaborations
Shota Ikeda has collaborated with notable colleagues, including Shuji Fujiwara and Keiji Kusumoto. These partnerships have further enhanced the impact of his research and innovations in the medical community.
Conclusion
Shota Ikeda's work in developing a heart failure model animal represents a significant advancement in medical research. His contributions are vital for the future of heart failure treatment and prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile